Masaharu Mori
Corporate Officer/Principal at Laboratoires OncoTherapy Science France SARL
Profile
Masaharu Mori is currently a Manager at Laboratoires OncoTherapy Science France SARL since 2014.
Prior to this, he was the President & Representative Director at OncoTherapy Science, Inc. from 2014 to 2017.
He also served as the President & Representative Director at Immunas Pharma, Inc. and as the President at Dojin Iyaku-Kako Co., Ltd.
Masaharu Mori active positions
Companies | Position | Start |
---|---|---|
Laboratoires OncoTherapy Science France SARL | Corporate Officer/Principal | 2014-09-30 |
Former positions of Masaharu Mori
Companies | Position | End |
---|---|---|
ONCOTHERAPY SCIENCE, INC. | President | 2017-02-26 |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | President | - |
Dojin Iyaku-Kako Co., Ltd.
Dojin Iyaku-Kako Co., Ltd. Pharmaceuticals: MajorHealth Technology Dojin Iyaku-Kaku Co., Ltd. is engaged in the development, production, and distribution of pharmaceutical products and pharmaceutical raw materials. The company was established in 1946 and is based in Tokyo, Japan. | President | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ONCOTHERAPY SCIENCE, INC. | Health Technology |
Private companies | 3 |
---|---|
Dojin Iyaku-Kako Co., Ltd.
Dojin Iyaku-Kako Co., Ltd. Pharmaceuticals: MajorHealth Technology Dojin Iyaku-Kaku Co., Ltd. is engaged in the development, production, and distribution of pharmaceutical products and pharmaceutical raw materials. The company was established in 1946 and is based in Tokyo, Japan. | Health Technology |
Laboratoires OncoTherapy Science France SARL | |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
- Stock Market
- Insiders
- Masaharu Mori